The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.
Baunwall, Simon Mark Dahl Terveer, Elisabeth M Dahlerup, Jens Frederik Erikstrup, Christian Arkkila, Perttu Vehreschild, Maria Jgt Ianiro, Gianluca Gasbarrini, Antonio Sokol, Harry Kump, Patrizia K
Baunwall, Simon Mark Dahl
Terveer, Elisabeth M
Dahlerup, Jens Frederik
Erikstrup, Christian
Arkkila, Perttu
Vehreschild, Maria Jgt
Ianiro, Gianluca
Gasbarrini, Antonio
Sokol, Harry
Kump, Patrizia K
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2021-07-19
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.
Translated Title
Published in
Lancet Reg Health Eur 2021; 19;9:100181
Abstract
In 2019, 31 FMT centres from 17 countries reported a total of 1,874 (median 25, quartile 10-64) FMT procedures; 1,077 (57%) with Clostridioides difficile infection (CDI) as indication, 791 (42%) with experimental indications, and 6 (0•3%) unaccounted for. Adjusted to population size, 0•257 per 100,000 population received FMT for CDI and 0•189 per 100,000 population for experimental indications. With estimated 12,400 (6,100-28,500) annual cases of multiple, recurrent CDI and indication for FMT in Europe, the current European FMT activity covers approximately 10% of the patients with indication. The participating centres demonstrated high safety standards and adherence to international consensus guidelines. Formal or informal regulation from health authorities was present at 21 (68%) centres.